pdufa.bio

KRESLADI (marnetegragene autotemcel)

Updated ยทnext FDA decision on the calendar

KRESLADI (marnetegragene autotemcel) 1 FDA decision on record below. Every date links its source.

RCKT catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · Mar 27, 2026 ✓ ApprovedRCKT

Questions

When is KRESLADI (marnetegragene autotemcel)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for KRESLADI (marnetegragene autotemcel); 1 FDA decision is on record below.

What happened at KRESLADI (marnetegragene autotemcel)'s most recent FDA decision?

On Mar 27, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.